Sera Prognostics, Inc. Class A Common Stock (SERA)

Price$2.29

Value ScoreD

Growth ScoreD

Momentum ScoreB

Favorite Metrics

Price vs S&P 500 (26W)-39.16%

Price vs S&P 500 (4W)21.82%

VGM Score37.49

Market Capitalization$89.67M

All Metrics

Book Value / Share (Quarterly)$1.73

P/TBV (Annual)1.53x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-33.06%

Cash Flow / Share (Quarterly)$-0.70

Price vs S&P 500 (YTD)-30.53%

Gross Margin (TTM)-191.23%

Net Profit Margin (TTM)-56385.96%

EPS (TTM)$-0.65

10-Day Avg Trading Volume0.10M

EPS Excl Extra (TTM)$-0.65

Revenue Growth (5Y)21.98%

EPS (Annual)$-0.67

ROI (Annual)-42.34%

Gross Margin (Annual)-102.47%

Net Profit Margin (5Y Avg)-30822.98%

Cash / Share (Quarterly)$1.21

Revenue Growth QoQ (YoY)-63.16%

ROA (Last FY)-31.32%

Revenue Growth TTM (YoY)-50.43%

EBITD / Share (TTM)$-0.72

ROE (5Y Avg)-46.55%

Operating Margin (TTM)-64235.09%

Cash Flow / Share (Annual)$-0.68

P/B Ratio1.33x

P/B Ratio (Quarterly)1.18x

Net Income / Employee (Annual)$-449,700

EV / Revenue (TTM)1499.97x

Net Interest Coverage (TTM)-57.35x

ROA (TTM)-30.95%

EPS Incl Extra (Annual)$-0.67

Current Ratio (Annual)1.69x

Quick Ratio (Quarterly)2.02x

3-Month Avg Trading Volume0.06M

52-Week Price Return43.13%

Revenue / Employee (TTM)$800

Tangible BV / Share (Quarterly)$1.71

P/S Ratio (Annual)1107.08x

Asset Turnover (Annual)0.00x

52-Week High$4.09

Operating Margin (5Y Avg)-33100.58%

EPS Excl Extra (Annual)$-0.67

CapEx CAGR (5Y)37.08%

26-Week Price Return-31.23%

Quick Ratio (Annual)1.62x

13-Week Price Return14.50%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)2.12x

Enterprise Value$85.50M

Revenue / Share Growth (5Y)11.20%

Asset Turnover (TTM)0.00x

Revenue / Employee (Annual)$1,100

Pretax Margin (Annual)-39417.28%

Cash / Share (Annual)$1.01

3-Month Return Std Dev82.08%

Gross Margin (5Y Avg)2.91%

Net Income / Employee (TTM)$-452,700

ROE (Last FY)-42.34%

Net Interest Coverage (Annual)-16.01x

EPS Basic Excl Extra (Annual)$-0.67

Receivables Turnover (TTM)3.17x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-0.65

Receivables Turnover (Annual)3.52x

ROI (TTM)-41.01%

P/S Ratio (TTM)1573.22x

Pretax Margin (5Y Avg)-30822.98%

Revenue / Share (Annual)$0.00

Tangible BV / Share (Annual)$1.91

Price vs S&P 500 (52W)18.76%

Year-to-Date Return-22.37%

5-Day Price Return4.57%

EPS Normalized (Annual)$-0.67

ROA (5Y Avg)-35.29%

Net Profit Margin (Annual)-39417.28%

Month-to-Date Return6.02%

Cash Flow / Share (TTM)$-1.20

EBITD / Share (Annual)$-0.75

Operating Margin (Annual)-45066.67%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-46.30%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-0.65

P/TBV (Quarterly)1.19x

P/B Ratio (Annual)1.51x

Pretax Margin (TTM)-56385.96%

Book Value / Share (Annual)$1.94

Price vs S&P 500 (13W)6.25%

Beta0.87x

Revenue / Share (TTM)$0.00

ROE (TTM)-41.02%

52-Week Low$1.37

vGradeD

gGradeD

mGradeB

vgmGradeD

Show chart for

Earnings Surprise History

Q1 26-0.17est. -0.17

Analyst Recommendations

Mar 2026

Apr 2026

May 2026

Jun 2026

4.33

Industry Peers — Health Services(28)

Symbol	Value Score	Growth Score	Momentum Score	Price
SERASera Prognostics, Inc. Class A Common Stock	D	D	B	$2.29
NTRANatera, Inc. Common Stock	F	A	C	$215.31
DGXQuest Diagnostics Inc.	C	D	C	$200.29
LHLabcorp Holdings Inc.	C	D	C	$265.15
EXASExact Sciences Corp	F	B	B	$0.00
GHGuardant Health, Inc. Common Stock	F	A	B	$125.61
CAICaris Life Sciences, Inc. Common Stock	F	A	D	$16.49
CELCCelcuity Inc. Common Stock	—	—	C	$88.28
RDNTRadNet, Inc. Common Stock	D	C	C	$54.34
VCYTVeracyte, Inc.	D	A	B	$48.73
GRALGRAIL, Inc. Common Stock	D	A	C	$59.98

About

Sera Prognostics develops blood-based diagnostic tests that predict individualized maternal health risks, including premature birth, preeclampsia, gestational diabetes, and stillbirth. Using proprietary proteomics and bioinformatics technology, the company commercializes biomarker tests and predictive analytics products to improve maternal and neonatal health outcomes.